Autism Spectrum Disorder Epidemiology Forecast 2026-2035

Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by challenges in social communication and behavior. According to the World Health Organization (WHO), it is estimated that worldwide in 2021, about 1 in 127 persons had autism, reflecting an average prevalence that varies across regions. As per autism spectrum disorder epidemiology forecasts, global awareness and diagnosis trends continue to influence reported prevalence and data interpretation.

Autism Spectrum Disorder Epidemiology Forecast Report Coverage
The analyst's “Autism Spectrum Disorder Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of autism spectrum disorder. It projects the future incidence and prevalence rates of autism spectrum disorder cases across various populations. The study covers age, gender, and type as major determinants of the autism spectrum disorder population. The report highlights patterns in the prevalence of autism spectrum disorder over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of autism spectrum disorder (ASD) in the 8 major markets.

Regions Covered
- The United States
- Germany
- France
- Italy
- Spain
- The United Kingdom
- Japan
- India
Autism Spectrum Disorder Understanding: Disease Overview
Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition characterized by persistent challenges in social communication, interaction, and restricted or repetitive patterns of behavior. It typically arises from a combination of genetic predisposition and environmental influences affecting early brain development. Symptoms generally appear in early childhood and vary widely in severity, forming a “spectrum.” ASD includes subtypes previously classified separately, such as autistic disorder, Asperger syndrome, and pervasive developmental disorder-not otherwise specified (PDD-NOS), now unified under a single diagnostic category.

Autism Spectrum Disorder Epidemiology Perspective
The autism spectrum disorder epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The analyst provides both current and predicted trends for the autism spectrum disorder epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for autism spectrum disorder and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.
- According to Agappe Diagnostics Ltd. a population-based study in India screened 28,070 children aged 1-10 years and reported an autism spectrum disorder prevalence of 0.15% with broader estimates suggesting about 1.2 to 2 million affected children nationwide and indicating a relatively low but significant burden across diverse regions.
- As per the Centers for Disease Control and Prevention, children born in 2018 showed a cumulative autism spectrum disorder diagnosis rate of 22.6 per 1,000 by age 48 months, compared to 13.1 per 1,000 for those born in 2014, reflecting increasing early identification and improved surveillance across multiple monitoring sites.
- According to Margarita Kilili Lesta et al. 2024 a cross-sectional study in Cyprus reported a prevalence of 1.8% with a male representation of 80.3% and a gender ratio of 4.1 to 1, showing significantly higher likelihood among males and greater detection in pre-primary and special school populations.
- As per Kelly A Shaw et al. 2025 autism spectrum disorder prevalence among 8-year-old children in the United States was 32.2 per 1,000, with boys showing 49.2 per 1,000 compared to girls at 14.3 per 1,000, indicating marked gender differences and variation across geographic regions and demographic groups.
- According to Kelly A Shaw et al. 2025 prevalence differences also varied across racial groups, with higher rates among Asian, Black, Hispanic, and multiracial children compared to non-Hispanic White children and mixed associations with neighborhood income, suggesting disparities influenced by both demographic and socioeconomic factors.
Country-wise Autism Spectrum Disorder Epidemiology
The autism spectrum disorder epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

Overall, epidemiological estimates indicate relatively consistent autism spectrum disorder prevalence, with regional variations in diagnosis rates and reporting practices. According to Agappe Diagnostics Ltd., Autism in India: Rising Numbers and Growing Awareness, a 2025 analysis estimates ASD prevalence at approximately 1.12% to 1.5% among children aged 2-9 years. According to Fundaneed, Spain may have about 1 in 100 individuals affected, though fewer than 100,000 are formally diagnosed. According to NHS England data, prevalence is about 1 in 100, with similar estimates from global studies across developed regions.

Autism Spectrum Disorder: Treatment Overview
The management of autism spectrum disorder focuses on early, individualized, and multidisciplinary interventions to improve functional outcomes. Behavioral therapies, particularly Applied Behavior Analysis (ABA), are widely used to enhance communication, social, and learning skills. Speech and language therapy, occupational therapy, and social skills training are also essential components. While no cure exists, pharmacological treatments such as antipsychotics or antidepressants may be prescribed to manage associated symptoms like irritability, anxiety, or hyperactivity. Family support, educational interventions, and structured environments play a crucial role in long-term care and development.

Key Questions Answered
- What are the key findings of autism spectrum disorder epidemiology in the 8 major markets?
- What will be the total number of patients with autism spectrum disorder across the 8 major markets during the forecast period?
- What was the country-wise autism spectrum disorder epidemiology scenario in the 8 major markets in the historical period?
- Which country will have the highest number of autism spectrum disorder patients during the forecast period of 2026-2035?
- Which key factors would influence the shift in the patient population of autism spectrum disorder during the forecast period of 2026-2035?
- What are the currently available treatments for autism spectrum disorder?
- What are the disease risks, signs, symptoms, and unmet needs of autism spectrum disorder?
Scope of the Autism Spectrum Disorder Epidemiology Report
The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of autism spectrum disorder based on several factors.

Autism Spectrum Disorder Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
The autism spectrum disorder report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.